NT-proBNP in the lowest quartile (<1115 pg/mL) 12 weeks after randomization was associated with a lower risk of subsequent cardiovascular death or HF hospitalization regardless of the baseline concentration [85]. The gene discussed is NPPB; the disease is hydrops fetalis.